Chartwell Investment Partners, LLC Global Blood Therapeutics, Inc. Transaction History

Chartwell Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 08, 2018	SELL	$38.0 - $51.1 $1.24 Million - $1.66 Million	-32,519 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$38.7 - $50.15 $321,403 - $416,495	-8,305 Reduced 20.34%	32,519 $1.47 Million
Q1 2018 May 08, 2018	BUY	$39.6 - $65.9 $43,520 - $72,424	1,099 Added 2.77%	40,824 $1.61 Million
Q1 2018 May 08, 2018	SELL	$39.6 - $65.9 $43,520 - $72,424	-1,099 Reduced 2.69%	39,725 $1.92 Million
Q4 2017 Feb 08, 2018	BUY	$29.7 - $45.7 $1.21 Million - $1.87 Million	40,824	40,824 $1.61 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.